ADB-FUBICA

ADB-FUBICA

Systematic (IUPAC) name
(S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide
Clinical data
Legal status	CA: Schedule II
Identifiers
CAS Number	1801338-23-7
Chemical data
Formula	C22H24FN3O2
Molar mass	381.45 g/mol
SMILES O=C(C1=CN(CC2=CC=C(F)C=C2)C3=C1C=CC=C3)N[C@@H](C(C)(C)C)C(N)=O
InChI InChI=1S/C22H24FN3O2/c1-22(2,3)19(20(24)27)25-21(28)17-13-26(18-7-5-4-6-16(17)18)12-14-8-10-15(23)11-9-14/h4-11,13,19H,12H2,1-3H3,(H2,24,27)(H,25,28)/t19-/m1/s1 Key:QIFOZYUACLDTAJ-LJQANCHMSA-N

ADB-FUBICA is a drug that acts as a potent agonist for the cannabinoid receptors, with EC₅₀ values of 2.6 nM at CB₁ and 3.0 nM at CB₂.^[1][2]

See also

• AB-FUBICA
• AB-FUBINACA
• ADB-FUBINACA

References

1. Banister, Samuel D.; Moir, Michael; Stuart, Jordyn; Kevin, Richard C.; Wood, Katie E.; Longworth, Mitchell; Wilkinson, Shane M.; Beinat, Corinne; Buchanan, Alexandra S.; Glass, Michelle; Connor, Mark; McGregor, Iain S.; Kassiou, Michael (2015). "Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA". ACS Chemical Neuroscience 6 (9): 1546. doi:10.1021/acschemneuro.5b00112. PMID 26134475.
2. Zhenhua Qian, Zhendong Hua, Cuimei Liu, Wei Jia (November 2015). "Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances". Forensic Toxicology. doi:10.1007/s11419-015-0297-2.